

Veenat 100mg Capsule (Imatinib)
Manufactured By
Natco
Pack Of
120
Salt Composition
Imatinib
Storage
Keep in cold place
Fast Delivery

Easy Returns

Secure Payments

Up to 60% Discounts
ALL SUBSTITUTES
Overview
Veenat 100mg capsule is an anticancer medicine which is used in chronic myeloid leukemia & acute lymphocytic leukemia and gastrointestinal stromal tumors. It contains an active ingredient known as imatinib. It works by inhibiting the specific proteins called tyrosine kinases that promote the growth and multiplication of cancer cells. This can stop the cancer progression and cancer load inside the body. The imatinib 100mg capsule can also be used to treat a skin tumor called dermatofibrosarcoma protuberans and a type of bone marrow condition known as aggressive systemic mastocytosis.
The capsule must be taken orally and swallowed whole with water and should not be crushed, chewed, or opened. The prescribed dose and duration of the Imatinib 100mg capsule depend on the patient's condition and response to treatment. It is taken with food to reduce stomach-related problems. Patients are advised not to change the dosage and timings prescribed by the doctors because it can cause severe side effects.
Common side effects include nausea, vomiting, diarrhea, abdominal discomfort, muscle cramps, fatigue, headache, skin rash, and swelling around the eyes, face, hands, or ankles. A few patients can undergo severe side effects, including severe fluid retention, liver problems, significant bleeding, severe skin reactions and heart problems. Most of the imatinib 100mg capsule side effects can leave when the body adapts to the medicine. However, report to your doctor if you experience serious side effects.
The medicine may harm an unborn baby. Women who can become pregnant should use effective contraception during treatment. Patients must list all medicines, supplements, and herbal products that they are taking. The Imatinib 100mg capsule must be used under medical oversight or medical supervision only. Attend regular tests and follow-ups to monitor the medicine response and reduce side effects. Before making any adjustments, changing the dose, or stopping the treatment, consult with your doctor to maximize the benefit.
Quick Product Facts
| Field | Publication wording |
|---|---|
| Brand | veenat |
| Generic / Active Ingredient | Imatinib |
| Strength | 100 |
| Dosage Form | Capsule |
| Manufacturer / Marketer | Natco |
| Pack Size | 120 |
| Prescription Required | Yes |
| Therapeutic Categories | Cancer Medicines |
Uses and Indications
Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia, Gastrointestinal Stromal Tumors (GIST) and dermatofibrosarcoma protuberans.
Side Effects of Veenat 100mg Capsule
Imatinib 100mg Capsule is a chemical salt-based anticancer medication. Therefore, it has several common side effects like any other medicine. Consult your doctor if side effects persist for a longer period of time.
Common side effects of Imatinib 100mg Capsule are:
● Vomiting
● Nausea
● Muscle Cramps
● Abdominal Pain
● Diarrhea
● Rashes
● Cough
● Weight Gain
● Dizziness
● Edema
Serious Side Effects:
● Stomach Bleeding
● Severe Skin Reaction
● Blood Disorders
● Heart Failure Symptoms
● Pleural Effusion
Veenat 100mg Capsule Dosage and How To Take It
Imatinib 100mg Capsule is administered orally with water, usually with food. The duration and dosage of the capsule depend on the cancer type, its stage and the overall health of the patient on the doctor's guidance. Avoid breaking, chewing and biting the capsule for effective results.
Safety Advice for Veenat 100mg Capsule
- ● Alcohol: It is advisable not to consume alcohol while taking Imatinib 100mg Capsule, as it can worsen the side effects. It is advised to consult your doctor for further information.
- ● Pregnancy: Imatinib 100mg Capsule is considered unsafe for pregnancy due to fetal harm and teratogenic nature. Please consult your doctor in such a condition.
- ● Breastfeeding: Breastfeeding is not advisable during the imatinib 100mg capsule course. Consult your doctor for more information.
- ● Driving: It is advisable not to drive, as you may feel dizzy after taking Imatinib 100mg Capsule.
- ● Kidney: Share your medical history related to kidney cancer or any other issue with your doctor before taking Imatinib 100mg Capsule.
- ● Liver: Notify your doctor about any liver disease or infection before starting Veenat 100mg capsule course.
FAQs About Veenat 100mg Capsule
Is Imatinib 100mg Capsule advisable during Pregnancy?
Imatinib 100mg Capsule causes harm to the growing fetus as well as is teratogenic in nature. Thus, it is not recommended during pregnancy for treatment.
Can Imatinib 100mg Capsule be given with any other medicine?
No, imatinib 100mg is not given with other chemotherapeutic drugs due to its imatinib salt. As it can have certain side effects on interacting with other drugs. Consult your doctor about the same
What should I do if I miss the Imatinib 100mg Capsule dose?
Take the Imatinib 100mg Capsule as soon as you remember it unless it is the time for the next dose. Do not double the dosage. Also inform your doctor about the missed dose.
How to take Imatinib 100mg Capsule?
Imatinib 100mg Capsule is taken orally with water without breaking, chewing or biting the capsule. It can be taken with or without food. Follow the doctor's prescribed dosage and time.
What all cancers are treated with Imatinib 100mg Capsule?
Imatinib 100mg Capsule is used to treat a broad spectrum of cancers. It mainly treats Chronic Myeloid Leukemia (CML), Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL), Gastrointestinal Stromal Tumors (GIST), Dermatofibrosarcoma Protuberans (a rare type of skin cancer), etc.
References
● Arora, B., Gota, V., Menon, H., Sengar, M., Nair, R., Patial, P., & Banavali, S. D. (2013). Therapeutic drug monitoring for imatinib: Current status and Indian experience. Indian Journal of Medical and Paediatric Oncology, 34(03), 224-228.
● Buchdunger, E., O'Reilley, T., & Wood, J. (2002). Pharmacology of imatinib (STI571). European journal of cancer, 38, S28-S36.
● Lyseng-Williamson, K., & Jarvis, B. (2001). Imatinib. Drugs, 61(12), 1765-1774.
● Deininger, M., Buchdunger, E., & Druker, B. J. (2005). The development of imatinib as a therapeutic agent for chronic myeloid leukemia. Blood, 105(7), 2640-2653.
Marketer Details
Natco
Disclaimer
Globanspharma main goal is to ensure that its consumers get correct, authentic, and reliable information that has been examined by medical professionals. This website's content has only been created for informational purposes. However, this is not meant to replace the medical advice and treatment given by a qualified physician. The information presented herein may not cover everything about particular lab tests, medicines, and health conditions, all possible side effects, and warnings. Please discuss all your queries related to any medication and illness with your doctor. We intend to support and maintain the doctor-patient relationship, not to substitute it or take its place.











